Navigation Links
DuPont Licenses Breakthrough Automotive Coating Technology to German Paint Maker
Date:1/16/2008

Helps Automakers Reduce Crucial Energy and Capital Costs

WILMINGTON, Del., Jan. 16 /PRNewswire-FirstCall/ -- Bollig & Kemper, a German manufacturer of coatings for the European auto industry, has signed a license agreement for DuPont EcoConcept, a patented coatings technology that enables auto manufacturers to realize substantial reductions in energy use, environmental emissions and capital costs.

Under the license agreement, the Cologne-based paint maker will manufacture and sell water-based basecoats for use in the EcoConcept process at automotive manufacturing plants in Germany and elsewhere in Europe.

EcoConcept technology was recognized in 2007 when the authoritative auto industry publication Automotive News presented DuPont with a PACE Award, the highest honor in a competition staged annually by the publication.

"The global automotive industry has never been as competitive as it is today, so every cost advantage is vital," said Marty McQuade, vice president and general manager -- DuPont Automotive Systems. "This technology offers multiple benefits, providing auto manufacturers with a competitive advantage by delivering identifiable, measurable and meaningful cost and environmental savings."

EcoConcept eliminates one complete coating layer, the primer-surfacer, and combines it into a single environmentally compliant water-based basecoat. As a result, a spray booth and curing oven are eliminated from the auto production line.

Specifically, the technology reduces energy consumption and solvent emissions related to the painting process by approximately 25 percent. Carbon dioxide emissions are reduced by 45-50 kilograms per vehicle built. The combination of two coats into one reduces production time and saves on the cost of equipment needed for the conventional three-coat process.

DuPont EcoConcept technology currently is used at two Volkswagen plants in Mexico and Spain. Some 200,000 cars have been prod
'/>"/>

SOURCE DuPont
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. DuPont Focused on Meeting Global Demands for Greater Safety & Protection
2. DuPont Pledges $250,000 to Nature Conservancy for Water Quality Initiative
3. DuPont Scores a Hat Trick for Innovation
4. DuPont Responds to Spelter, W.Va., Lawsuit Decision
5. DuPont Group Vice President Briefs Investors on Performance Materials Segment
6. DuPont Names Phuong Tram Chief Information Officer
7. DuPont Selects South Carolina Site for Planned $500 Million Investment to Expand Production of High-Performance Kevlar(R) Fiber
8. New DuPont(TM) Agility(TM) SG Herbicide Offers Wheat Growers Answers to Changing Weed Control Needs
9. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
10. Sanofi-Aventis renews licenses for Genomatix chip analysis pipeline
11. NuVasive Licenses Its Insert and Rotate Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)... The Palomino Group, a le... organization, today announced the launch of its n... to the biopharmaceutical industry. The company, b...ursement and commercialization consulting services...al device, and other healthcare companies. , ...
(Date:7/23/2008)... Output of New Molecular Entities Drops to Histori... Competition from Generics Companies, LONDON, Jul...omson,Reuters today announced the availability of ...eutical R&D Factbook, an indispensable reference,a...harmaceutical R&D,corporate finance, business str...
(Date:7/23/2008)... IVF clinic expands welcome to out-of-state...Newswire/ -- The recent California,Supreme Court d...the,commitment of the Reproductive Science Center ...fertility practices, to serving gays and lesbians ...ation of same-sex marriage supports RSC,s,long-hel...
(Date:7/23/2008)... Full line of vaccines for Immigration and Natural... Health, BALTIMORE, July 23 /PRNewswire/ -...is applying for an immigrant visa for entry into t...r permanent residence. Applicants,must show proof ...es, as,recommended by the U.S. Advisory Committee ...
Breaking Medicine News(10 mins):Health News:The Palomino Group Announces Launch of Meeting Support Services Business Unit 2Health News:The Palomino Group Announces Launch of Meeting Support Services Business Unit 3Health News:Thomson Reuters Publishes CMR International's 2008 Pharmaceutical R&D Factbook, Now Available for the First Time Online 2Health News:California Supreme Court Gay-Marriage Ruling Reinforces Top Bay Area Fertility Specialists' Support for Same-Sex Couples 2Health News:USCIS Tightens Vaccination Requirements 2
... contemplating raising the retirement age for civi...life expectancy and a soaring pension bill//. Mor... penchant by authorities to grant arbitrary extens...being cited among the reasons for the move. A sou...
...g lost two of their cows to rabies, a farmer's ext...ccinated against the disease for a whopping// Rs.4...cows. Two cows of Rajkishore Prasad Singh, a farm...were bitten by a rabid dog last month and died of ...
...0 babies have died at the B.C. Roy Memorial Hospit...ernment's abysmal healthcare facilities and bringi...occurred in this only state-run referral hospital ...e Thursday come at a time when the state health de...
...ctor Mickey Rourke says he has calmed down with ag...e has failed.// Rourke said he no longer jumps in... other day, there was some drunk guy troubling me ...efit of the doubt and I told the waitress, 'I want...
Other Medicine News:Health News:Pakistan civil servants may retire at 62 2Health News:Crib deaths revisit Kolkata hospital, 22 infants die 2
(Date:7/23/2008)...ire/ -- InCode BioPharmaceutics, Inc.,an emerging...nical test,results demonstrating the utility of th... the rare chronic blood disorder paroxysmal noctur...l be presented at the XXII,International Complemen...08., The only treatment currently available for P...
(Date:7/23/2008)... Work with Protein Therapeutics that Mod...AMBRIDGE, Mass., July 23 /- Taligen T...a corporate growth plan with the,appointment of Ab...d the,establishment of its headquarters in Cambrid...D., a co-founder of the company who remains presid...
(Date:7/22/2008)...a multi-center 293-patient European, trial -, h...ymbol: CYT, MONTREAL, July 22 /PRNewswire-FirstCa...ader in cryotherapy products to treat cardiac,arrh...resented from three,European study centers using t...ublished earlier today in the Journal of the Ameri...
(Date:7/22/2008)...s Development Initiative bring MJFF,s,current acti...nuary 20,2009, NEW YORK, July 22 /PRNewswire-USN...ry of transformative treatments and a cure for Par...r Parkinson,s Research has awarded,$2.7 million in... awards,were granted under MJFF,s Therapeutics Dev...
Breaking Medicine Technology:InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Kiadis Pharma Receives Orphan Drug Designation for Rhitol 28TM 29 From the FDA 4587 1Kiadis Pharma Receives Orphan Drug Designation for Rhitol 28TM 29 From the FDA 4587 2New study in JCSM finds that obesity can predict upper airway obstruction amongst children 16798 1New study in JCSM finds that obesity can predict upper airway obstruction amongst children 16798 2New study in JCSM finds that obesity can predict upper airway obstruction amongst children 16798 3Beyond the terminal 3A Palliative care 16795 1Beyond the terminal 3A Palliative care 16795 2Figure Skater Peggy Fleming Teams With HealthSaver 3A Allergies and Asthma Relief 16793 1Figure Skater Peggy Fleming Teams With HealthSaver 3A Allergies and Asthma Relief 16793 2Figure Skater Peggy Fleming Teams With HealthSaver 3A Allergies and Asthma Relief 16793 3Figure Skater Peggy Fleming Teams With HealthSaver 3A Allergies and Asthma Relief 16793 4Figure Skater Peggy Fleming Teams With HealthSaver 3A Allergies and Asthma Relief 16793 5Figure Skater Peggy Fleming Teams With HealthSaver 3A Allergies and Asthma Relief 16793 6
...-FirstCall/ --,CuraGen Corporation and TopoTarget ...cal data on intravenous belinostat,(PXD101), a his...ed,for the treatment of cancer, are expected to be... , One oral and one poster presentation discussing...made at the 2007 American Society,of Clinical Onco...
...e-FirstCall/ --,Idenix Pharmaceuticals, Inc. , a b... development and commercialization of drugs for,th...seases,announced today that 11 abstracts have bee...Disease Week (DDW) meeting, to,be held in Washingt...re available on the DDW web site at <a target="_bl...
Other Medicine Technology:CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 2CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 3CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 4CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 5Idenix Announces Data Presentations at the 2007 Digestive Disease,Week Meeting 2Idenix Announces Data Presentations at the 2007 Digestive Disease,Week Meeting 3Idenix Announces Data Presentations at the 2007 Digestive Disease,Week Meeting 4Idenix Announces Data Presentations at the 2007 Digestive Disease,Week Meeting 5Idenix Announces Data Presentations at the 2007 Digestive Disease,Week Meeting 6Idenix Announces Data Presentations at the 2007 Digestive Disease,Week Meeting 7
Antigenic Free Protein S, ELISA Method
Immuno-turbidimetric Assay for Antithrombin III Antigen. Suspension of microlatex particles coated with specific antibodies.
Colorimetric Assay of Unfractionated Heparins (UH) and Low Molecular Weight Heparins (LMWH).Chromogenic substrate CBS 31.39, ~13 moles/vial, freeze-dried; purified bovine ATIII, freeze-dried; purifie
Substrate Plasma for Factor VII Assay by STA© Analyzers. Freeze-dried human plasma from which factor VII has been removed by selective immuno-adsorption.
Medicine Products: